Pharma Focus Europe
ThermoFisher Scientific - Go beyond the catalog

Amgen Invests US$325 million to Construct New Plant in Central Ohio

Introduction:

Amgen plans to construct new biomanufacturing plant. The new plant will support the increasing demand for Amgen's medicines in the United States.

Features:

The new state-of-the-art manufacturing facility, enables to bring new innovative medicines for patients.

This cutting edge facility will be used by 400 ohioans for package medicines and benefit millions of people’s life those battling with serious illnesses. Moreover, environmental sustainability will be a major priority and it also ensures to maximise energy efficiency and waste reduction, plans to make operations carbon neutral over the next several years.

After the completion of the project, it will provide new job opportunities for technicians and engineers, along with quality assurance, quality control, administrative and management positions.

The construction of the new facility is expected to be fully operational by 2024.

Specifications:

NameAmgen
TypeNew Construction
BudgetUS$325 million
Year2024
Latest Issue
Get instant
access to our latest e-book
Pall+CytivaAdvertisement
Lab Indonesia 2024Sartorius Lab Balance CleaningWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies 2024Equinix accelerated medical research...World Vaccine Congress Washington 2024EUROPEAN PHARMA OUTSOURCING SUMMIT 2024Pharma 2024